Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis

Abstract

Our pilot study demonstrates the usefulness of estimating OPN levels to differentiate between pancreatic cancer and chronic pancreatitis. Higher OPN levels over 102 ng/ml could be a potential diagnostic biomarker for pancreatic cancer.